NCT00968760
- Conditions
- B-cell Lymphoma, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,023 public trials
2,029 recruiting studies
Immunoproliferative Disorders trial results
NCT04682405
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT06170151
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Irccs San Raffaele Milan, Italia, Italy
NCT02561273
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT01088750
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
- Locations
-
- Universitaetsklinikum Giessen-Marburg Giessen, Germany
NCT01913730
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Irccs Crob Rionero in Vulture, Potenza, Italy
NCT03734601
- Conditions
- Acute Myeloid Leukemia, B-cell Lymphoma, Bone Marrow Diseases, +33 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT01421524
- Conditions
- Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +35 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- UCLA Neuro-Oncology Program Los Angeles, California, United States
- UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States
- University Of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT05137847
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Eisai Trial Site 3 Nagoya, Japan
- Eisai Trial Site 1 Osaka, Japan
- Eisai Trial Site 2 Tokyo, Japan
NCT06153576
- Conditions
- Bone Metastases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- CHU NICE Nice, Alpes Maritimes, France